Singapore markets close in 5 hours 46 minutes
Straits Times Index
3,329.88 -0.21 (-0.01%) Nikkei
38,789.52 -65.85 (-0.17%) Hang Seng
18,554.01 -267.15 (-1.42%) FTSE 100
8,254.18 -63.41 (-0.76%) Bitcoin USD
68,728.05 +364.09 (+0.53%) CMC Crypto 200
1,449.22 -47.24 (-3.16%)
MRK May 2024 125.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:29PM EDT. Market open.
| Previous close | 0.1000 |
| Open | 0.2000 |
| Bid | 0.3800 |
| Ask | 0.4800 |
| Strike | 125.00 |
| Expiry date | 2024-05-31 |
| Day's range | 0.2000 - 0.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 445 |
ReutersMerck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Merck did not immediately respond to Reuters' request for a comment, while Eyebiotech declined to comment. Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and the UK, that seeks to treat patients with sight-threatening diseases. Its major drug in clinical stage, Restoret, aims to treat retinal diseases characterized by leakage that can lead to impaired vision.
- Investing.com
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.
Business WireMerck Announces Third-Quarter 2024 Dividend
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend
© 2024 Yahoo. All rights reserved.